IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

AH Equity Partners Bio II, L.L.C.

Q2 2022 Holdings

Filed 2022-08-15 | 4 holdings | $142.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
EQRx, Inc.Common Stock26886C107$81.8K17,438,46557.4%
Nautilus Biotechnology, Inc.(NAUT)Common Stock63909J108$43.8K16,298,00630.8%
Erasca, Inc.(ERAS)Common Stock29479A108$13.9K2,500,0009.8%
InVitae Corporation(NVTA1EUR)Common Stock46185L103$2.9K1,170,1272.0%